NU566 Week 4

NU566 Week 4

Student Name

Purdue University Global

NU566 NP I – Introduction to Primary Care for the Nurse Practitioner

Prof. Name:

Date

Evaluation of Suspected Hyperthyroidism and Thyroid Disease

Persistent insomnia accompanied by unexplained weight loss, palpitations, tachycardia, nervousness, frequent bowel movements, hair thinning, hyperreflexia, and an enlarged thyroid gland strongly suggests hyperthyroidism, with Graves’ disease being the most likely cause. Confirming the diagnosis requires thyroid function testing, thyroid-specific antibody testing, and appropriate imaging to identify the underlying etiology and guide treatment. Early recognition is essential because untreated hyperthyroidism increases the risk of cardiovascular complications, osteoporosis, atrial fibrillation, and thyroid storm.

Clinical Presentation

A 65-year-old retired woman presents with progressively worsening insomnia that has persisted for several months. Initially, she experienced occasional difficulty sleeping, but her symptoms have gradually become more frequent. She now has trouble both falling asleep and remaining asleep, often lying awake for one to two hours before falling asleep and consistently awakening between 2:00 AM and 3:00 AM. She reports being an extremely light sleeper and is easily awakened by environmental noise.

In addition to sleep disturbances, she reports multiple symptoms commonly associated with excessive thyroid hormone production, including unintentional weight loss, nervousness, intermittent palpitations, frequent bowel movements, heartburn, occasional headaches, nasal congestion, rhinorrhea, and progressive hair thinning.

She denies depression, excessive anxiety, fever, dizziness, vertigo, visual disturbances, dysphagia, chest pain, shortness of breath, abdominal pain, nausea, vomiting, muscle weakness, gait abnormalities, skin rashes, and lymph node enlargement.

History of Present Illness

The patient’s insomnia has progressively worsened over several months without an identifiable trigger. Initially intermittent, her sleep disturbance now occurs multiple nights each week and significantly affects her quality of life.

Associated symptoms include:

• Unintentional weight loss

• Increased nervousness

• Intermittent palpitations

• Frequent bowel movements

• Heartburn

• Hair thinning

• Occasional headaches

• Nasal congestion

• Rhinorrhea

The gradual progression of systemic symptoms strongly suggests an endocrine disorder rather than isolated primary insomnia.

Review of Systems

Constitutional

Positive findings

• Progressive weight loss

• Nervousness

• Persistent insomnia

Negative findings

• Fever

• Fatigue

• Depression

• Persistent anxiety

Head and Neck

The patient reports occasional headaches without dizziness or vertigo. She denies neck pain, stiffness, or limited range of motion.

Eyes, Ears, Nose, and Throat (EENT)

Positive findings

• Nasal congestion

• Rhinorrhea

Negative findings

• Vision changes

• Diplopia

• Blurred vision

• Ear pain

• Sinus pain

• Tongue or lip swelling

• Difficulty swallowing

Cardiovascular

Positive findings

• Palpitations

Negative findings

• Chest pain

• Chest pressure

Respiratory

The patient denies:

• Dyspnea

• Chest tightness

• Cough

Gastrointestinal

Positive findings

• Heartburn

• Frequent bowel movements

Negative findings

• Abdominal pain

• Nausea

• Vomiting

Hematologic/Lymphatic

The patient denies:

• Easy bruising

• Enlarged lymph nodes

Skin

Hair thinning is present without rashes, lesions, or discoloration.

Musculoskeletal

The patient denies:

• Muscle weakness

• Joint pain

• Joint stiffness

• Gait changes

Past Medical History

The patient reports no known chronic medical conditions.

Surgical History

No previous surgeries.

Family History

Her grandmother had thyroid disease, increasing the patient’s genetic risk for thyroid dysfunction.

Social History

The patient maintains an active lifestyle despite retirement. She walks daily, plays tennis every weekend, and frequently socializes with friends.

She denies:

• Tobacco use

• Alcohol consumption

• Recreational drug use

Allergies

No known drug allergies.

Current Medications

• Daily calcium supplement

• Multivitamin

Physical Examination

Vital Signs

General Appearance

The patient is alert, oriented, well-developed, and appears her stated age. She is in no acute distress and does not appear toxic.

Head and Neck

Neck examination demonstrates full range of motion without tenderness. No cervical lymphadenopathy is noted. Diffuse thyroid enlargement (goiter) is present.

Eyes, Ears, Nose, and Throat

Pupils are equal, round, and reactive to light and accommodation. Tympanic membranes are normal bilaterally. Nasal passages are patent without erythema or drainage. The oropharynx appears clear without erythema or swelling.

Cardiovascular

Cardiac examination reveals tachycardia without murmurs or carotid bruits. No peripheral edema is observed.

Respiratory

Lungs are clear to auscultation bilaterally with symmetrical chest expansion and normal respiratory effort.

Gastrointestinal

The abdomen is soft, non-tender, and non-distended with normal bowel sounds. No hepatosplenomegaly or abdominal masses are detected.

Skin

Skin is warm, dry, and intact without lesions or rashes.

Musculoskeletal and Neurological

Muscle tone and bulk are appropriate. Deep tendon reflexes are hyperactive. No focal neurological deficits are identified.

Diagnostic Evaluation

The patient’s symptoms and physical examination warrant comprehensive thyroid testing to confirm hyperthyroidism and determine its underlying cause.

Recommended Laboratory Studies

Initial laboratory evaluation should include:

• Thyroid-Stimulating Hormone (TSH)

• Free Thyroxine (Free T4)

• Free Triiodothyronine (Free T3)

• Total T3

• Total T4

• Thyroid-Stimulating Immunoglobulin (TSI)

Recommended Imaging

A thyroid scan should be performed to evaluate thyroid function, identify diffuse uptake suggestive of Graves’ disease, and distinguish hyperthyroidism from toxic multinodular goiter or thyroiditis when clinically indicated.

Assessment

The patient’s history, family history, examination findings, and systemic symptoms strongly support hyperthyroidism as the primary diagnosis.

Key findings supporting hyperthyroidism include:

• Progressive insomnia

• Unintentional weight loss

• Tachycardia

• Palpitations

• Hyperreflexia

• Diffuse thyroid enlargement

• Frequent bowel movements

• Hair thinning

• Family history of thyroid disease

Among all causes of hyperthyroidism, Graves’ disease remains the leading diagnosis because it commonly presents with diffuse goiter, thyroid overactivity, and positive thyroid-stimulating antibodies.

Primary Diagnosis

Hyperthyroidism with Secondary Insomnia

Hyperthyroidism occurs when excessive thyroid hormone production accelerates metabolism and overstimulates multiple body systems.

Common manifestations include:

• Insomnia

• Tachycardia

• Weight loss

• Tremor

• Nervousness

• Heat intolerance

• Hyperreflexia

• Diarrhea

• Diffuse goiter

Sleep disturbances frequently become the presenting complaint before thyroid disease is recognized.

Differential Diagnoses

Graves’ Disease

Graves’ disease is the most common cause of hyperthyroidism and results from thyroid-stimulating autoantibodies that continuously activate the thyroid gland.

Supporting findings include:

• Diffuse goiter

• Weight loss

• Tachycardia

• Palpitations

• Nervousness

• Hyperreflexia

• Increased bowel movements

• Positive family history

Toxic Multinodular Goiter

Toxic multinodular goiter may also produce excessive thyroid hormone and should remain in the differential diagnosis until imaging distinguishes diffuse thyroid enlargement from nodular disease.

Primary Insomnia

Primary insomnia is less likely because the patient exhibits multiple objective systemic findings that suggest endocrine dysfunction rather than an isolated sleep disorder.

Generalized Anxiety Disorder

Although anxiety may cause insomnia and palpitations, the presence of goiter, tachycardia, hyperreflexia, weight loss, and frequent bowel movements strongly favors hyperthyroidism over anxiety alone.

Management Plan

Diagnostic Follow-Up

Complete all recommended laboratory testing and thyroid imaging to establish the definitive diagnosis and identify the underlying cause.

Pharmacologic Treatment

Treatment depends on laboratory confirmation and the underlying etiology.

Potential therapies include:

• Methimazole

• Propylthiouracil (PTU)

• Beta-blockers for symptom control

• Radioactive iodine therapy

• Thyroidectomy when medically indicated

Endocrinology Referral

Referral to an endocrinologist is recommended for comprehensive evaluation, confirmation of Graves’ disease, management of thyroid nodules if present, and long-term treatment planning.

Lifestyle Recommendations

Patients should be encouraged to:

• Practice consistent sleep hygiene.

• Reduce caffeine intake, especially in the afternoon and evening.

• Maintain regular physical activity while avoiding excessive exertion if symptoms worsen.

• Consume a balanced, nutrient-rich diet.

• Seek immediate medical attention if chest pain, worsening palpitations, or increasing neck swelling develops.

Follow-Up

A follow-up visit should occur within four weeks to review laboratory results, imaging findings, establish the final diagnosis, and initiate definitive therapy.

Key Clinical Takeaways

• Persistent insomnia in older adults should prompt evaluation for endocrine disorders rather than being attributed solely to aging.

• Hyperthyroidism commonly presents with weight loss, tachycardia, palpitations, nervousness, frequent bowel movements, tremors, and insomnia.

• Graves’ disease remains the leading cause of hyperthyroidism worldwide.

• Serum TSH, Free T4, and Free T3 are the primary laboratory tests used to diagnose hyperthyroidism.

• Early diagnosis reduces the risk of atrial fibrillation, osteoporosis, heart failure, and thyroid storm.

Frequently Asked Questions

What are the most common symptoms of hyperthyroidism?

Common symptoms include unexplained weight loss, rapid heartbeat, palpitations, insomnia, tremors, anxiety, heat intolerance, increased bowel movements, excessive sweating, hair thinning, and thyroid enlargement.

Why does hyperthyroidism cause insomnia?

Excess thyroid hormone overstimulates the nervous system, increases metabolic activity, and elevates heart rate. These physiological changes make it difficult to fall asleep, remain asleep, and achieve restorative sleep.

Which laboratory tests diagnose hyperthyroidism?

The initial evaluation includes:

• TSH

• Free T4

• Free T3

Additional testing such as TSI antibodies and thyroid imaging helps identify Graves’ disease and other causes of thyroid overactivity.

What is the difference between Graves’ disease and hyperthyroidism?

Hyperthyroidism refers to excessive thyroid hormone production regardless of the cause. Graves’ disease is an autoimmune disorder and the most common cause of hyperthyroidism.

When should patients be referred to an endocrinologist?

Referral is appropriate when laboratory testing confirms hyperthyroidism, Graves’ disease is suspected, thyroid nodules are identified, symptoms are severe, or advanced treatments such as radioactive iodine therapy or surgery are being considered.

Conclusion

Hyperthyroidism should be strongly considered in older adults presenting with persistent insomnia accompanied by unexplained weight loss, tachycardia, palpitations, hyperreflexia, increased bowel movements, hair thinning, and thyroid enlargement. A structured diagnostic evaluation beginning with serum TSH, Free T4, and Free T3 testing, followed by thyroid antibody testing and imaging when appropriate, allows clinicians to identify the underlying cause promptly. Early diagnosis and evidence-based treatment improve symptom control, reduce long-term complications, and enhance overall quality of life.

References

American Thyroid Association. (2023). Graves’ disease. https://www.thyroid.org/graves-disease/

American Thyroid Association. (2023). Hyperthyroidism (overactive thyroid). https://www.thyroid.org/hyperthyroidism/

Jameson, J. L., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. (2022). Harrison’s principles of internal medicine (21st ed.). McGraw-Hill Education. https://accessmedicine.mhmedical.com

McCance, K. L., & Huether, S. E. (2023). Pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier. https://www.elsevier.com/books/pathophysiology-the-biologic-basis-for-disease-in-adults-and-children/mccance

NU566 Week 4

National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Hyperthyroidism. https://www.niddk.nih.gov/health-information/endocrine-diseases/hyperthyroidism

Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., & Walter, M. A. (2016). 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, 26(10), 1343–1421. https://doi.org/10.1089/thy.2016.0229